SPHK1 and Huntington disease: From the early stage of Huntington’s disease, biopsies of patients show increased SGPL1 and decreased SphK1 in postmortem brain tissue200, and SphK1 stimulation can exert neuroprotective effects in a mouse model of Huntington’s disease201.